Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

10
Number of overlapping holdings
12.2%
% of AGNG's 82 holdings also in GDOC
27.0%
% of GDOC's 39 holdings also in AGNG
Overlap by Weight
Sector Drift (AGNG minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in AGNG |
Weight in GDOC |
Overlap | |
---|---|---|---|---|
BOSTON SCIENTIFIC CORP | 3.1% | 8.3% | 3.1% | |
ELI LILLY & CO | 3.1% | 9.7% | 3.1% | |
ABBVIE INC | 3.1% | 6.4% | 3.1% | |
NOVO NORDISK A/S-B | 3.0% | 3.8% | 3.0% | |
MERCK & CO. INC. | 2.8% | 4.0% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
AGNG Overweight Relative to GDOC
CHUGAI PHARMACEUTICAL CO LTD | 3.6% | |
UCB SA | 3.2% | |
ALCON, INC. | 3.1% | |
ROCHE HOLDING AG-BR | 3.1% | |
EDWARDS LIFESCIENCES CORP | 3.1% | |
ASTRAZENECA PLC-SPONS ADR | 3.0% | |
STRYKER CORP | 3.0% | |
WELLTOWER, INC. | 3.0% | |
REGENERON PHARMACEUTICALS | 2.9% | |
JOHNSON & JOHNSON | 2.8% |
AGNG Underweight Relative to GDOC
ELI LILLY & CO | -6.7% | |
INTUITIVE SURGICAL INC | -5.8% | |
ABBOTT LABORATORIES | -5.2% | |
BOSTON SCIENTIFIC CORP | -5.2% | |
UNITEDHEALTH GROUP INC | -5.2% | |
ASTRAZENECA PLC | -4.2% | |
COOPER COS INC/THE | -3.8% | |
BIOMARIN PHARMACEUTICAL INC | -3.3% | |
ABBVIE INC | -3.3% | |
CSL LIMITED | -3.1% |